Welcome to BioIT Alliance Community Server Sign in
HOME | SEARCH | MEMBER DIRECTORY | CALENDAR | VISITOR FAQ
Company Information

    The Genesis of GenomeQuest

    The company began in the multi-national Human Genome Project. While at INRIA, founder and high-performance computing luminary Dr. Jean-Jacques Codani developed and licensed technology used to map the human genome. The original product, called Biofacet, was a high-powered bioinformatic engine aimed at expert users,created by Jean Jacques Codani, Ph.D., at Gene-IT in France in the late 1990s. Gene-IT hired Ronald Ranauro to head world wide sales in 2002. In 2005, the company received funding and moved to Westborough, Massachusetts, and was renamed GenomeQuest, where Ranauro now is president and CEO, and Codani is chief scientific officer. GenomeQuest improved the original search engine and developed a web-based software application for managing, mining and sharing sequence data. The company has more than 150 customers and growing, including patent lawyers and researchers at pharmaceutical, and biotechnology firms as well as academic labs.

This Member

Syndication

Gene-IT

GenomeQuest releases v5.0

GenomeQuest, Inc., the leader in sequence information, today announced that it has released GenomeQuest™ 5.0, the latest edition of its industry-leading high throughput sequence search, analysis and data management platform.

The newest edition of the GenomeQuest platform allows users to search entire lists of genes and protein sequences at once and to classify, sort, and report results from all the queries as a single aggregated result. The intuitive web interface provides users with enhanced features for organizing, managing and viewing their search results as well as annotation and sequence information, and finally saving their work in improved custom display formats.

Ronald Ranauro, President and CEO of GenomeQuest, Inc., said, “GenomeQuest 5.0 lets end-users ask global questions of their sequence data. Researchers can quickly assess the patent landscape of a list of proteins, or classify quickly a list of transcripts into their relevant genes and pathways.”

He added, “We’re very pleased with the latest release of the GenomeQuest software, as it advances our mission to give our customers desktop-level access to all the functionality of a bioinformatics facility, via our hosted or in-house platform. Users can fully implement custom sequence search and results analysis, backed by GenomeQuest algorithms, sequence content and data management, without concerns about hardware constraints, database management, or administration.”

New features of GenomeQuest 5.0 include:

• New Annotation Layout
• Grouping – by Patent, Patent Family, Gene Name, Organism, Query, Subject
• Save your Workspace (e.g. checkboxes & filters, columns, sorting, etc.)
• Save your View (named and reusable results templates)
• Improved Reporting
• Advanced Syntax for Keyword Searching (to be available in September 2008)
• Vector NTI Connection

A complete description of new features can be found at: http://www.genomequestlive.com/GQtest/doc/GQL-update.html

Published Tuesday, July 22, 2008 3:09 PM by Gene-IT
Filed Under:

Comments

No Comments
Anonymous comments are disabled

About Gene-IT

The Genesis of GenomeQuest

The company began in the multi-national Human Genome Project. While at INRIA, founder and high-performance computing luminary Dr. Jean-Jacques Codani developed and licensed technology used to map the human genome. The original product, called Biofacet, was a high-powered bioinformatic engine aimed at expert users,created by Jean Jacques Codani, Ph.D., at Gene-IT in France in the late 1990s. Gene-IT hired Ronald Ranauro to head world wide sales in 2002. In 2005, the company received funding and moved to Westborough, Massachusetts, and was renamed GenomeQuest, where Ranauro now is president and CEO, and Codani is chief scientific officer. GenomeQuest improved the original search engine and developed a web-based software application for managing, mining and sharing sequence data. The company has more than 150 customers and growing, including patent lawyers and researchers at pharmaceutical, and biotechnology firms as well as academic labs.